| Financial Year |
March 31 2023 |
| Monetary Funds |
3,497,886,888.72 |
| Held-for-trading Financial Assets |
1,831,375.93 |
| Notes Receivable |
1,377,145,511.18 |
| Accounts Receivable |
1,467,165,401.54 |
| Advances to Suppliers |
344,341,605.85 |
| Other Receivables |
1,497,342,433.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,547,415,875.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,235,067.36 |
| Total Current Assets |
10,019,910,699.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,303,067.14 |
| Long-term Equity Investment |
162,804,044.58 |
| Investment Properties |
60,933,824.55 |
| Fixed Assetes |
10,267,894,631.36 |
| Under-construction Projects |
5,229,126,976.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,497,480,468.07 |
| R&D expenses |
-- |
| Goodwill |
922,340,274.19 |
| Long-Term Deferred and Prepaid Expenses |
1,035,206,864.16 |
| Deferred Income Tax Assets |
120,779,883.63 |
| Other Non-Current Assets |
562,380,924.29 |
| Sub-Total of Non-Current Assets |
19,893,393,017.81 |
| Total Assets |
29,913,303,717.17 |
| Short-Term Loans |
6,723,011,351.03 |
| Trading Financial liabilities |
7,145,131.81 |
| Notes Payable |
1,096,942,770.00 |
| Accounts Payable |
1,782,055,685.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,143,124.39 |
| Taxes Payable |
44,458,079.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,753,117.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
766,253,460.44 |
| Other Current Liabilities |
961,847,783.70 |
| Sub-Total of Current Liabilities |
11,816,540,150.74 |
| Long-term Loans |
2,903,696,460.12 |
| Bonds Payable |
617,718,532.85 |
| Long-Term Accounts Payable |
364,706,096.98 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,531,579.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,104,007,894.84 |
| Total Liabilities |
15,920,548,045.58 |
| Paid-In Capital(Or Share Stock) |
2,842,833,818.00 |
| Capital Surplus |
3,349,216,428.45 |
| Surplus Reserve |
843,737,718.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,226,986,651.00 |
| Minority Stockholder's Interest |
584,115,892.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,408,639,778.94 |
| Owner's Equity（Stockholder's Equity） |
13,992,755,671.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,913,303,717.17 |
